J Gomez-Navarro

Author PubWeight™ 9.89^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial.	Clin Cancer Res	2000	1.14
2	An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression.	Mol Ther	2001	1.10
3	Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid.	Hum Gene Ther	2000	0.99
4	Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours.	Br J Cancer	2013	0.89
5	Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro.	Clin Cancer Res	2000	0.86
6	Adenoviral-mediated suicide gene therapy for ovarian cancer.	Mol Ther	2000	0.86
7	An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites.	Gynecol Oncol	2001	0.86
8	Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications.	Clin Cancer Res	2001	0.83
9	Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix.	Gynecol Oncol	2001	0.81
10	Transcriptional targeting for ovarian cancer gene therapy.	Gynecol Oncol	2001	0.79
11	Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy.	Clin Cancer Res	1999	0.78
12	9 intracellular single-chain antibodies for gene therapy.	Methods Mol Med	2000	0.75
13	Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.	Biochem Biophys Res Commun	1998	0.75
14	Cisplatin and UFT modulated with leucovorin for the treatment of Advanced non-small-cell lung cancer.	Am J Clin Oncol	1996	0.75